Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
2015 · BMC Research Notes · 12 citations
https://doi.org/10.1186/s13104-015-1126-8
Y
Yasuhiro Kato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
129
Papers
1.5K
Citations
19
h-index
29
i10-index
Yasuhiro Kato is an academic researcher from The University of Osaka. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Neuroscience and Neural Engineering & Colorectal Cancer Treatments and Studies. The author has an h-index of 19, co-authored 110 publications.
ORCID: 0000-0001-8585-1995Papers by this author
worksInduction of resistance to neurotrophic tropomyosin‐receptor kinase inhibitors by <scp>HMGCS2</scp> via a mevalonate pathway
2024 · Cancer Medicine · 3 citations
https://doi.org/10.1002/cam4.7393
Clinical Characteristics and Risk Prediction Score in Patients With Mild-to-Moderate Coronavirus Disease 2019 in Japan
2022 · Cureus · 1 citations
https://doi.org/10.7759/cureus.31210
Determination of a Celastramycin A binding protein.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0108957.g001
Host control of persistent Epstein–Barr virus infection
2026 · Nature · 0 citations
https://doi.org/10.1038/s41586-026-10274-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat